PCI Biotech Holding Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Ronny Skuggedal
Chief Executive Officer (CEO)
NOK 2.4m
Compensación total
| Porcentaje del salario del CEO | 82.8% |
| Permanencia del CEO | 11.1yrs |
| Participación del CEO | 0.1% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 8.5yrs |
Actualizaciones recientes de la dirección
Recent updates
We're Keeping An Eye On PCI Biotech Holding's (OB:PCIB) Cash Burn Rate
Aug 05
We Think PCI Biotech Holding (OB:PCIB) Needs To Drive Business Growth Carefully
Apr 21We're Hopeful That PCI Biotech Holding (OB:PCIB) Will Use Its Cash Wisely
Dec 16We're Not Very Worried About PCI Biotech Holding's (OB:PCIB) Cash Burn Rate
Apr 09What Type Of Shareholders Own The Most Number of PCI Biotech Holding ASA (OB:PCIB) Shares?
Feb 15PCI Biotech Holding (OB:PCIB) Is In A Good Position To Deliver On Growth Plans
Dec 22
Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -NOK 16m |
| Mar 31 2024 | n/a | n/a | -NOK 18m |
| Dec 31 2023 | NOK 2m | NOK 2m | -NOK 20m |
| Sep 30 2023 | n/a | n/a | -NOK 23m |
| Jun 30 2023 | n/a | n/a | -NOK 29m |
| Mar 31 2023 | n/a | n/a | -NOK 38m |
| Dec 31 2022 | NOK 2m | NOK 2m | -NOK 55m |
| Sep 30 2022 | n/a | n/a | -NOK 73m |
| Jun 30 2022 | n/a | n/a | -NOK 84m |
| Mar 31 2022 | n/a | n/a | -NOK 88m |
| Dec 31 2021 | NOK 2m | NOK 2m | -NOK 88m |
| Sep 30 2021 | n/a | n/a | -NOK 90m |
| Jun 30 2021 | n/a | n/a | -NOK 90m |
| Mar 31 2021 | n/a | n/a | -NOK 100m |
| Dec 31 2020 | NOK 3m | NOK 1m | -NOK 72m |
| Sep 30 2020 | n/a | n/a | -NOK 71m |
| Jun 30 2020 | n/a | n/a | -NOK 64m |
| Mar 31 2020 | n/a | n/a | -NOK 61m |
| Dec 31 2019 | NOK 2m | NOK 1m | -NOK 89m |
| Sep 30 2019 | n/a | n/a | -NOK 68m |
| Jun 30 2019 | n/a | n/a | -NOK 62m |
| Mar 31 2019 | n/a | n/a | -NOK 43m |
| Dec 31 2018 | NOK 2m | NOK 1m | -NOK 35m |
| Sep 30 2018 | n/a | n/a | -NOK 46m |
| Jun 30 2018 | n/a | n/a | -NOK 48m |
| Mar 31 2018 | n/a | n/a | -NOK 48m |
| Dec 31 2017 | NOK 1m | NOK 1m | -NOK 43m |
Compensación vs. Mercado: La compensación total ($USD220.55K) de Ronny está en línea con el promedio de empresas de tamaño similar en el mercado Norwegian ($USD300.00K).
Compensación vs. Ingresos: La compensación de Ronny ha aumentado mientras la empresa no es rentable.
CEO
Ronny Skuggedal (48 yo)
11.1yrs
Permanencia
NOK 2,443,000
Compensación
Mr. Ronny Skuggedal has been the Chief Financial Officer at PCI Biotech Holding ASA and PCI Biotech AS since joining in October 2013. He serves as Chief Executive Officer at PCI Biotech Holding ASA since S...
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Independent Chairman | 9.5yrs | NOK 395.00k | 0.33% NOK 163.7k | |
| Independent Director | 8.5yrs | NOK 260.00k | 0.035% NOK 17.2k | |
| Independent Director | 5.5yrs | NOK 260.00k | sin datos |
8.5yrs
Permanencia media
69yo
Promedio de edad
Junta con experiencia: La junta directiva de PCIB se considera experimentada (8.5 años de antigüedad promedio).